Incidence and clinical relevance of supraventricular tachyarrhythmias in pulmonary hypertension

Survival in Patients with Primary Pulmonary Hypertension

1991 • 3,369 citations

Bosentan Therapy for Pulmonary Arterial Hypertension

2002 • 2,715 citations

A Comparison of Continuous Intravenous Epoprostenol (Prostacyclin) with Conventional Therapy for Primary Pulmonary Hypertension

1996 • 2,590 citations

Primary Pulmonary Hypertension

1987 • 2,027 citations

Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebocontrolled study

2001 • 1,521 citations

Cellular and molecular pathobiology of pulmonary arterial hypertension

2004 • 1,521 citations

Long-term intravenous epoprostenol infusion in primary pulmonary hypertension

2002 • 1,383 citations

Continuous Subcutaneous Infusion of Treprostinil, a Prostacyclin Analogue, in Patients with Pulmonary Arterial Hypertension

2002 • 1,382 citations

ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summary

2001 • 1,324 citations

Survival in Primary Pulmonary Hypertension

2002 • 1,192 citations

Treatment of Supraventricular Tachycardia Due to Atrioventricular Nodal Reentry by Radiofrequency Catheter Ablation of Slow-Pathway Conduction

1992 • 1,155 citations

Chronic Rapid Atrial Pacing

1995 • 1,052 citations

Continuous Intravenous Epoprostenol for Pulmonary Hypertension Due to the Scleroderma Spectrum of Disease

2000 • 1,051 citations

ACC/AHA/ESC Guidelines for the Management of Patients With Supraventricular Arrhythmias—Executive Summary

2003 • 970 citations

Atrial fibrillation in heart failure: epidemiology, pathophysiology, and rationale for therapy

2003 • 933 citations

Catheter Ablation for Atrial Fibrillation in Congestive Heart Failure

2004 • 885 citations

Medical Therapy For Pulmonary Arterial Hypertension

2004 • 853 citations

Tachycardia-Induced Cardiomyopathy: A Review of Animal Models and Clinical Studies

1997 • 789 citations

Sitaxsentan Therapy for Pulmonary Arterial Hypertension

2003 • 723 citations

Beraprost therapy for pulmonary arterial hypertension

2003 • 627 citations

Survival with first-line bosentan in patients with primary pulmonary hypertension

2005 • 611 citations

Acc/aha/esc guidelines for the management of patients with atrialfibrillation: executive summary a report of the american college ofcardiology/american heart association task force on practice guideli

2001 • 608 citations

Hemodynamic Effects of an Irregular Sequence of Ventricular Cycle Lengths During Atrial Fibrillation

1997 • 584 citations

Long-Term Treatment of Primary Pulmonary Hypertension with Aerosolized Iloprost, a Prostacyclin Analogue

2000 • 583 citations

Prognostic significance of atrial fibrillation in advanced heart failure. A study of 390 patients.

1991 • 572 citations

ACC/AHA/ESC Guidelines for the Management of Patients With Atrial Fibrillation: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the North American Society of Pacing and Electrophysiology

2001 • 571 citations

Survival in Primary Pulmonary Hypertension with Long-Term Continuous Intravenous Prostacyclin

1994 • 558 citations

Tachycardia-induced cardiomyopathy: A reversible form of left ventricular dysfunction

1986 • 537 citations

Primary pulmonary hypertension

2003 • 526 citations

Eisenmenger syndrome. Factors relating to deterioration and death

1998 • 522 citations

Heart Failure and Sudden Death in Patients With Tachycardia-Induced Cardiomyopathy and Recurrent Tachycardia

2004 • 363 citations

Primary Pulmonary Hypertension

2000 • 361 citations

Diagnostic value of tachycardia features and pacing maneuvers during paroxysmal supraventricular tachycardia

2000 • 356 citations

Inhaled Iloprost To Treat Severe Pulmonary Hypertension: An Uncontrolled Trial

2000 • 281 citations

Differentiation of atypical atrioventricular node re-entrant tachycardia from orthodromic reciprocating tachycardia using a septal accessory pathway by the response to ventricular pacing

2001 • 275 citations

Prognostic value of the presence and development of atrial fibrillation in patients with advanced chronic heart failure

2000 • 259 citations

Clinical Efficacy of Sitaxsentan, an Endothelin-A Receptor Antagonist, in Patients With Pulmonary Arterial Hypertension

2002 • 243 citations

Atrial Fibrillation and Ventricular Dysfunction

2004 • 234 citations

Atrioventricular nodal reentry. Clinical, electrophysiological, and therapeutic considerations.

1993 • 229 citations

Prostanoid therapy for pulmonary arterial hypertension

2004 • 219 citations

Chronic Supraventricular Tachycardia

1985 • 161 citations

New Treatments for Pulmonary Arterial Hypertension

2002 • 153 citations

Incidence, Predictive Factors, and Prognostic Significance of Supraventricular Tachyarrhythmias in Congestive Heart Failure

2000 • 145 citations

Newly Diagnosed Atrial Fibrillation

2004 • 134 citations

Increase in radionuclide left ventricular ejection fraction after eardioversion of chronic atrial fibrillation in idiopathic dilated cardiomyopathy

1992 • 103 citations

Pulmonary Arterial Hypertension

2004 • 100 citations

Ventricular Arrhythmias and Autonomic Profile in Patients with Primary Pulmonary Hypertension

2003 • 73 citations

Atrioventricular nodal reentry.

1987 • 68 citations

Heart rate variability in severe right or left heart failure: the role of pulmonary hypertension and resistances

2004 • 47 citations

Atrial fibrillation in patients with heart failure

2003 • 25 citations

[Chronic supraventricular tachycardia].

1971 • 21 citations